文献速递重症综合管理与镇静镇痛

荷兰高龄ICU患者短期与1年死亡率趋势:2008至2014年回顾性研究

Trends in short-term and 1-year mortality in very elderly intensive care patients in the Netherlands: a retrospective study from 2008 to 2014.
PubMed 文献 · Intensive Care Med · 2017-07-13
一句话结论2008至2014年荷兰31个ICU中,80岁及以上高龄ICU患者经风险调整的ICU、住院及3、6、12个月死亡率均显著逐年下降,降幅与80岁以下患者相似。

该回顾性队列研究利用荷兰国家重症监护评估基金会数据,纳入2008至2014年31个ICU收治的216196例患者,其中80岁及以上高龄患者28284例(13.1%)。采用广义线性混合效应模型分析经APACHE III评分、合并症和入院类型调整后的短期(ICU/住院)与长期(3、6、12个月)死亡率变化趋势。结果显示高龄患者经风险调整的ICU死亡率(调整OR 0.97,95%CI 0.95-0.99)和住院死亡率(调整OR 0.92,95%CI 0.91-0.93)逐年显著下降,3、6、12个月死亡率亦显著下降(调整OR分别为0.96、0.96、0.97)。80岁以下患者呈现相似的显著下降趋势。作者结论认为,在其研究环境中,高龄患者从医疗质量改善中获得的生存获益几乎与年轻患者相当。

要点

  • 2008至2014年,80岁及以上高龄ICU患者经风险调整的ICU死亡率逐年显著下降(调整OR 0.97,95%CI 0.95-0.99)。
  • 同期高龄患者经风险调整的住院死亡率逐年显著下降(调整OR 0.92,95%CI 0.91-0.93)。
  • 高龄患者经风险调整的3、6、12个月死亡率亦逐年显著下降(调整OR分别为0.96、0.96、0.97)。
  • 80岁以下患者经风险调整的短期和长期死亡率也呈现相似的显著逐年下降。
  • 作者认为,在其研究环境中高龄患者从医疗质量改善中获得的获益几乎与年轻患者相当。

适用人群与场景

  • 2008至2014年收入荷兰31个ICU的患者,包括80岁及以上高龄患者(28284例,占13.1%)和80岁以下患者。

研究设计与关键结果

  • 研究类型:回顾性队列研究,使用荷兰国家重症监护评估基金会数据,覆盖31个ICU。
  • 样本量:共纳入216196例ICU患者,其中80岁及以上高龄患者28284例(13.1%)。
  • 随访数据可获得性:3个月死亡率随访数据210005例(97.1%),6个月202551例(93.7%),12个月176847例(81.8%)。
  • 粗ICU死亡率从17.6%降至13.0%,粗住院死亡率从30.7%降至21.0%。
  • 高龄患者经风险调整(APACHE III评分、合并症、入院类型)的ICU死亡率逐年下降,调整OR 0.97(95%CI 0.95-0.99);住院死亡率调整OR 0.92(95%CI 0.91-0.93)。
  • 高龄患者经风险调整的3、6、12个月死亡率逐年显著下降,调整OR分别为0.96(95%CI 0.95-0.97)、0.96(95%CI 0.94-0.97)、0.97(95%CI 0.95-0.98)。
  • 80岁以下患者经风险调整的短期和长期死亡率也呈现相似的显著逐年下降。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在其研究环境中高龄患者从医疗质量改善中获得的生存获益几乎与年轻患者相当。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: To describe the trends in short-term and long-term mortality in very elderly intensive care unit (ICU) patients between 2008 and 2014.

METHODS: A retrospective cohort study was conducted using data from the National Intensive Care Evaluation Foundation from 31 Dutch ICUs. Generalized linear mixed-effects models were used to determine the change in adjusted short-term mortality (ICU/hospital deaths) and long-term mortality (3, 6, and 12 months after ICU admission) over the period 2008-2014 in very elderly patients and in patients less than 80 years old admitted to the ICU.

RESULTS: A total of 216,196 patients admitted to 31 ICUs in the period from 2008 to 2014 were included in the study, including 28,284 (13.1%) very elderly patients (80 years or older). Follow-up data for determination of 3-, 6-, and 12-month mortality were available for, respectively, 210,005 (97.1%), 202,551 (93.7%), and 176,847 (81.8%) ICU admissions. The crude ICU and in-hospital mortality decreased, respectively, from 17.6% to 13.0% and from 30.7% to 21.0%. The annual risk-adjusted ICU and in-hospital mortality of very elderly patients (adjusted for APACHE III score, comorbidities, and admission type) decreased significantly during the study period [adjusted odds ratio 0.97 (0.95-0.99) and 0.92 (0.91-0.93), respectively]. Additionally, the annual risk-adjusted 3-, 6-, and 12-month mortality decreased significantly from 2008 to 2014 [adjusted odds ratio 0.96 (0.95-0.97), 0.96 (0.94-0.97), and 0.97 (0.95-0.98), respectively]. A similar significant annual decrease in risk-adjusted short-term and long-term mortality was observed in patients aged less than 80 years.

CONCLUSIONS: Both short-term and long-term risk-adjusted mortality decreased significantly during the study period in both very elderly ICU patients and patients aged less than 80 years in the Netherlands. This study clearly shows that in our setting very elderly patients benefit almost as much as their younger counterparts from improvement in quality of care over time.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Karakus A, Haas LEM, Brinkman S, et al. Trends in short-term and 1-year mortality in very elderly intensive care patients in the Netherlands: a retrospective study from 2008 to 2014. Intensive Care Med. 2017. PMID: 28707185. doi:10.1007/s00134-017-4879-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。